Legend Biotech Corp Stock Performance
| LEGN Stock | USD 17.58 0.48 2.66% |
The company secures a Beta (Market Risk) of 0.13, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Legend Biotech's returns are expected to increase less than the market. However, during the bear market, the loss of holding Legend Biotech is expected to be smaller as well. At this point, Legend Biotech Corp has a negative expected return of -0.8%. Please make sure to verify Legend Biotech's skewness, and the relationship between the treynor ratio and rate of daily change , to decide if Legend Biotech Corp performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Legend Biotech Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in March 2026. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more
Actual Historical Performance (%)
One Day Return (2.66) | Five Day Return 2.45 | Year To Date Return (18.27) | Ten Year Return (52.49) | All Time Return (52.49) |
1 | Legend Biotech Analyst Reaffirms Buy Rating After Data R - GuruFocus | 11/26/2025 |
2 | Here is Why Legend Biotech Offers Such Promising Upside | 12/22/2025 |
3 | Legend Biotech Highlights Recent Business Updates at 44th Annual J.P. Morgan Healthcare Conference | 01/12/2026 |
4 | Legend Biotech to Present CARVYKTI Data at 2026 Tandem Meetings Reinforcing Growing Evidence Supporting Earlier Use | 01/21/2026 |
5 | Legend Biotech Corporation Sponsored ADR Given Consensus Recommendation of Moderate Buy by Brokerages | 01/26/2026 |
6 | Legend Biotech stock hits 52-week low at 18.07 By Investing.com - Investing.com Nigeria | 01/28/2026 |
7 | H.C. Wainwright Highlight Curative Potential of Legend Biotech Corporation s Carvykti Despite Sales Miss | 02/02/2026 |
8 | J.P. Morgan Maintains a Buy on Legend Biotech Corporation - MSN | 02/04/2026 |
9 | Legend Biotech shakes up board - MSN | 02/11/2026 |
| Begin Period Cash Flow | 1.3 B | |
| Total Cashflows From Investing Activities | -850.5 M |
Legend Biotech Relative Risk vs. Return Landscape
If you would invest 2,972 in Legend Biotech Corp on November 16, 2025 and sell it today you would lose (1,214) from holding Legend Biotech Corp or give up 40.85% of portfolio value over 90 days. Legend Biotech Corp is currently does not generate positive expected returns and assumes 3.4457% risk (volatility on return distribution) over the 90 days horizon. In different words, 30% of stocks are less volatile than Legend, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Legend Biotech Target Price Odds to finish over Current Price
The tendency of Legend Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 17.58 | 90 days | 17.58 | about 89.82 |
Based on a normal probability distribution, the odds of Legend Biotech to move above the current price in 90 days from now is about 89.82 (This Legend Biotech Corp probability density function shows the probability of Legend Stock to fall within a particular range of prices over 90 days) .
Legend Biotech Price Density |
| Price |
Predictive Modules for Legend Biotech
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Legend Biotech Corp. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Legend Biotech Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Legend Biotech is not an exception. The market had few large corrections towards the Legend Biotech's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Legend Biotech Corp, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Legend Biotech within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.85 | |
β | Beta against Dow Jones | 0.13 | |
σ | Overall volatility | 4.31 | |
Ir | Information ratio | -0.27 |
Legend Biotech Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Legend Biotech for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Legend Biotech Corp can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Legend Biotech Corp generated a negative expected return over the last 90 days | |
| Legend Biotech Corp has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 627.24 M. Net Loss for the year was (158.13 M) with profit before overhead, payroll, taxes, and interest of 132.68 M. | |
| Legend Biotech Corp currently holds about 791.26 M in cash with (144.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.11. | |
| Legend Biotech Corp has a poor financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Legend Biotech shakes up board - MSN |
Legend Biotech Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Legend Stock often depends not only on the future outlook of the current and potential Legend Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Legend Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 91.4 M | |
| Cash And Short Term Investments | 1.1 B |
Legend Biotech Fundamentals Growth
Legend Stock prices reflect investors' perceptions of the future prospects and financial health of Legend Biotech, and Legend Biotech fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Legend Stock performance.
| Return On Equity | -0.23 | ||||
| Return On Asset | -0.0692 | ||||
| Profit Margin | (0.26) % | ||||
| Operating Margin | (0.16) % | ||||
| Current Valuation | 2.66 B | ||||
| Shares Outstanding | 184.69 M | ||||
| Price To Book | 3.21 X | ||||
| Price To Sales | 3.57 X | ||||
| Revenue | 627.24 M | ||||
| Gross Profit | 132.68 M | ||||
| EBITDA | (113.16 M) | ||||
| Net Income | (158.13 M) | ||||
| Cash And Equivalents | 791.26 M | ||||
| Cash Per Share | 5.11 X | ||||
| Total Debt | 350.6 M | ||||
| Debt To Equity | 0.29 % | ||||
| Current Ratio | 3.83 X | ||||
| Book Value Per Share | 5.47 X | ||||
| Cash Flow From Operations | (144.03 M) | ||||
| Earnings Per Share | (1.28) X | ||||
| Market Capitalization | 3.25 B | ||||
| Total Asset | 1.67 B | ||||
| Retained Earnings | (1.66 B) | ||||
| Working Capital | 1.01 B | ||||
About Legend Biotech Performance
By examining Legend Biotech's fundamental ratios, stakeholders can obtain critical insights into Legend Biotech's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Legend Biotech is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 33.47 | 20.47 | |
| Return On Tangible Assets | (0.12) | (0.14) | |
| Return On Capital Employed | (0.25) | (0.26) | |
| Return On Assets | (0.12) | (0.13) | |
| Return On Equity | (0.20) | (0.21) |
Things to note about Legend Biotech Corp performance evaluation
Checking the ongoing alerts about Legend Biotech for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Legend Biotech Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Legend Biotech Corp generated a negative expected return over the last 90 days | |
| Legend Biotech Corp has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 627.24 M. Net Loss for the year was (158.13 M) with profit before overhead, payroll, taxes, and interest of 132.68 M. | |
| Legend Biotech Corp currently holds about 791.26 M in cash with (144.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.11. | |
| Legend Biotech Corp has a poor financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Legend Biotech shakes up board - MSN |
- Analyzing Legend Biotech's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Legend Biotech's stock is overvalued or undervalued compared to its peers.
- Examining Legend Biotech's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Legend Biotech's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Legend Biotech's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Legend Biotech's stock. These opinions can provide insight into Legend Biotech's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Legend Biotech Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Will Biotechnology sector continue expanding? Could Legend diversify its offerings? Factors like these will boost the valuation of Legend Biotech. Expected growth trajectory for Legend significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Legend Biotech data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (1.28) | Revenue Per Share | Quarterly Revenue Growth 0.7 | Return On Assets | Return On Equity |
Investors evaluate Legend Biotech Corp using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Legend Biotech's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Legend Biotech's market price to deviate significantly from intrinsic value.
Understanding that Legend Biotech's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Legend Biotech represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Legend Biotech's market price signifies the transaction level at which participants voluntarily complete trades.